Desipramine Market
Number of pages: 100 | Report Format: PDF | Published date: March 20, 2023
Historical Years – 2021 | Base Year – 2022 | Forecasted Years – 2023-2031
|
Report Attribute |
Details |
|
CAGR |
2.5% |
|
Base Year for Estimation |
2022 |
|
Forecast Period |
2023-2031 |
|
Historical Year |
2021 |
|
Segments Covered |
Indication, Age Group, Distribution Channel, and Region |
|
Regional Scope |
North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
According to the deep-dive market assessment study by Growth Plus Reports, the global desipramine market is expected to register a revenue CAGR of 2.5% during the forecast period from 2023 to 2031.
Desipramine Market Fundamentals
Antidepressants are medications used to treat depression, a mental health disorder characterized by persistent feelings of sadness, hopelessness, and loss of interest in activities that a person previously enjoyed. These medications affect neurotransmitters in the brain, such as serotonin, norepinephrine, and dopamine, responsible for regulating mood and emotions. Antidepressants can be classified into categories, such as selective serotonin reuptake inhibitors, tricyclic antidepressants (TCAs), and monoamine oxidase inhibitors (MAOIs). They are often used with therapy and lifestyle changes to treat depression and improve overall mental health. Antidepressants can have side effects and should only be taken under the guidance of a healthcare professional.
Desipramine is a medication that belongs to the class of TCAs. It is primarily used to treat depression but may also be used to treat other conditions. Desipramine works by increasing the levels of certain chemicals called neurotransmitters in the brain, which regulate mood and emotions. It is available in tablet form and should only be taken under the supervision of a healthcare provider due to potential side effects and interactions with other medications. Desipramine may interact with other medicines, such as MAOIs, and it should not be taken with alcohol or other substances that can cause drowsiness. It is important to follow the dosing instructions carefully and to talk to a healthcare provider about any concerns or questions related to the usage of desipramine.
Like other TCAs, desipramine has potential side effects, including dry mouth, constipation, blurred vision, dizziness, drowsiness, and weight gain. It can also cause more serious side effects, such as seizures, suicidal thoughts, and heart problems, so it should only be taken under the supervision of a healthcare provider.
Desipramine Market Dynamics
The growing number of depression cases worldwide is increasing the demand for anti-depression medication, including desipramine. According to the WHO, an estimated 3.8% of the global population is affected by depression, with a prevalence rate of 5% among adults and 5.7% among adults over 60. Desipramine has been used for several decades and has a well-established track record of effectiveness in treating depression. Healthcare providers familiar with the medication and its effects are more likely to prescribe these drugs, fueling the revenue growth of the desipramine market. The growing awareness of mental health issues and the importance of seeking treatment is expected to fuel the demand for desipramine. This societal trend is likely to continue driving revenue growth in the desipramine market as more individuals become aware of the importance of addressing mental health concerns and seek out effective treatments for conditions such as depression.
Desipramine is a generic drug that is generally more affordable than newer antidepressants, making it an attractive treatment option for patients who may not be able to afford more expensive medications, thus increasing the demand for desipramine. Moreover, in some conditions, such as neuropathic pain and ADHD, desipramine may also be prescribed, boosting the desipramine market revenue growth. Desipramine may be more widely used in emerging markets where newer antidepressants may not be as readily available or affordable. This is also expected to fuel the revenue growth of the desipramine market.
However, some side effects associated with desipramine include dry mouth, constipation, blurred vision, and fatigue, restricting the revenue growth of the global desipramine market. The rise in the development of new antidepressants with lesser side effects limits the usage of desipramine and hinders the revenue growth of the market.
Desipramine Market Ecosystem
The global desipramine market is analyzed from four perspectives: indication, age group, distribution channel, and region.
Desipramine Market by Indication
[56744]
Based on the indication, the global desipramine market is segmented into depression, bipolar disorder, and others.
The depression segment dominated the desipramine market with the largest revenue share. The rising prevalence of depression worldwide is increasing the demand for desipramine. According to WHO, around 280 million people in the world have depression. Desipramine has demonstrated its effectiveness as a treatment for depression in numerous clinical trials. It is frequently prescribed by healthcare professionals to patients who do not respond to alternative antidepressant medications or who suffer from severe side effects when taking other treatments. As a result, it has gained significant popularity among healthcare providers for managing depression. Desipramine is a generic medication, which makes it more affordable than many newer antidepressant medications. As a result, it may be more accessible to patients who cannot afford more expensive treatments for depression.
Desipramine Market by Age Group
Based on the age group, the global desipramine market is segmented into adults, geriatric, and pediatric & adolescents.
The adults segment account for a considerable revenue share of the desipramine market, due to the high prevalence of depression in adults. According to the American Psychiatric Association, 1 in every 15 adults in the U.S. are affected by depression, accounting for around 6.7%. Desipramine has a long-standing market presence and an established track record of usage among the adult population. Healthcare providers are well-versed in its advantages and drawbacks for this group, and patients who have benefited from desipramine may opt to continue using it due to its efficacy. Desipramine is an effective treatment for depression; it may not be the first-line treatment for other psychiatric conditions or certain patient populations.
The pediatric & adolescents segment is expected to experience a lucrative revenue growth rate during the forecast period. The rising prevalence of depression in pediatrics and adolescents is boosting segment growth. According to the WHO, depression is estimated to occur among 1.1% of adolescents aged 10-14 years and 2.8% of 15-19-year-olds. The enhanced awareness and diagnosis of depression in pediatrics and adolescents are fueling the demand for desipramine. As healthcare providers are more inclined to detect and treat depression in younger populations, the need for effective remedies is rising. The FDA has issued warnings about using many antidepressant medications in children and adolescents due to the potential risks of suicidal thoughts and behavior. This has limited the treatment options for pediatric depression, leading healthcare providers to consider desipramine as an alternative treatment. Desipramine is a generic medication, which makes it a more affordable treatment option for pediatric depression compared to newer, more expensive antidepressant medications.
Desipramine Market by Distribution Channel
Based on the distribution channel, the global desipramine market is segmented into retail pharmacies, hospital pharmacies, and online pharmacies.
The retail pharmacies segment accounts for a prominent revenue share of the desipramine market. Retail pharmacies are widely available to the general population, making it easier for patients to purchase desipramine, boosting segmental growth. Retail pharmacies are located in easily accessible locations, which allows patients to refill their desipramine prescriptions quickly and conveniently. Retail pharmacies offer competitive pricing for medications, including desipramine. This makes it a more affordable option for patients paying out-of-pocket for their medicines. Retail pharmacy staff members are trained to advise and support patients regarding their medications, including desipramine. This helps ensure that patients take their medications safely and correctly, which is also expected to fuel the segment growth.
The online pharmacies segment is expected to grow at the fastest revenue CAGR during the forecast period. Online pharmacies offer the convenience of ordering medications from the comfort of one's home without visiting a pharmacy physically. This can be especially appealing for patients living in rural or remote areas or having difficulty accessing physical pharmacies due to mobility issues. Some patients may feel uncomfortable discussing their medical conditions or medications with a pharmacist in person. Online pharmacies offer the option to purchase drugs discreetly without disclosing personal information. Online pharmacies are easily accessible, allowing patients to purchase their medications anytime without waiting for pharmacy hours of operation.
Desipramine Market by Region
Geographically, the global desipramine market has been segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
The North America region dominates the desipramine market with a significant revenue share in 2022. The prevalence of depression continues to increase in North America, increasing the demand for antidepressant medications like desipramine. According to the National Institute of Mental Health, estimated 21.0 million adults in the United States had at least one major depressive episode. This number represented 8.4% of all adults in the country. There is a growing awareness about the importance of mental health in North America, leading more people to seek treatment for their mental health issues, fueling regional growth. Desipramine is available in generic form, which has made it more affordable and accessible to patients. This has also increased competition among manufacturers, resulting in lower consumer prices. The governments of North American countries have introduced several policies and initiatives to improve access to mental health care. This includes increasing funding for mental health programs and reducing barriers to accessing mental health services. Such policies have helped to increase the demand for antidepressant medications, including desipramine.
Desipramine Market Competitive Landscape
The prominent players operating in the global desipramine market are:
Desipramine Market Strategic Developments
Desipramine is a medication that belongs to the class of tricyclic antidepressants (TCAs). It is primarily used to treat depression but may also be used to treat other conditions.
The rising prevalence of depression worldwide and increasing awareness regarding mental health are driving factors in the market.
The prominent players operating in the global desipramine market are Sanofi-Aventis U.S. LLC, Validus Pharmaceuticals LLC, Aa Pharma Inc, Apotex Corporation, and Amneal Pharmaceuticals LLC.
The depression segment dominates the global desipramine market.
The availability of alternative medications and side effects related to desipramine are some of the restricting factors of the market.
*Insights on financial performance are subject to the availability of information in the public domain